Jazz Pharmaceuticals plc (JAZZ) fundamentals score
Jazz Pharmaceuticals plc is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. It is dedicated to developing life-changing medicines for people with rare disease – often with limited or no therapeutic options.
Pharmaceutical Preparations · Healthcare · Listed on NASDAQ
Overall: 7.4 out of 10, Mixed fundamentals
- Growth: 6.4/10
- Profitability: 8.5/10
- Financial health: 7.2/10
- Earnings quality: 7.7/10
- Valuation: 6.9/10
Scores are calculated from Jazz Pharmaceuticals plc’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10